| Nome |
# |
|
Chronic cough in adults, file e2188be7-88e6-4564-e053-6605fe0a49d6
|
154
|
|
Classification of Malabsorption Syndromes, file e2188be7-17f8-4564-e053-6605fe0a49d6
|
151
|
|
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial, file e2188be7-10f2-4564-e053-6605fe0a49d6
|
126
|
|
Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity, file e2188be7-9737-4564-e053-6605fe0a49d6
|
67
|
|
Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study, file e2188be7-61d3-4564-e053-6605fe0a49d6
|
51
|
|
Adverse Reactions to Food: Allergies and Intolerances, file e2188be7-17f6-4564-e053-6605fe0a49d6
|
47
|
|
Severe asthma: One disease and multiple definitions, file e2188be8-0cc0-4564-e053-6605fe0a49d6
|
43
|
|
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry, file e2188be8-1375-4564-e053-6605fe0a49d6
|
43
|
|
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study, file c7b2436e-18af-4d68-9e59-1cf668a76f3d
|
42
|
|
Fecal calprotectin concentrations in alcoholic patients, file e2188be7-1d51-4564-e053-6605fe0a49d6
|
35
|
|
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects, file e2188be7-ad9f-4564-e053-6605fe0a49d6
|
32
|
|
Management of chronic refractory cough in adults, file e2188be7-8b9c-4564-e053-6605fe0a49d6
|
23
|
|
Tuberculosis and COVID-19 co-infection: description of the global cohort, file 0cd29bc8-ba92-4be7-8c40-c0c62e1e6ba3
|
20
|
|
Time course of exercise capacity in patients recovering from covid-19-associated pneumonia, file af1b81dc-2ffd-4826-9b08-aa88f2a1cec9
|
13
|
|
Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts, file 6ddf1702-29db-4717-8c11-4f06f73737f6
|
12
|
|
Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease, file 23680c6c-c757-4b92-a71c-97fa0aa81b6c
|
10
|
|
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries, file e2188be7-ae3f-4564-e053-6605fe0a49d6
|
10
|
|
Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: A case series, file f66926e7-412a-410e-b043-f55de5d86c3c
|
9
|
|
Patients and doctors group meetings: an innovative way to explore severe asthma backstage, file 27884757-b71a-4675-88c5-8f28d332abe2
|
8
|
|
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply, file 4f801f9f-dd37-4df9-b55d-586ce724d859
|
7
|
|
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial, file e2188be7-69f0-4564-e053-6605fe0a49d6
|
7
|
|
The Maugeri daily activity profile: A tool to assess physical activity in patients with chronic obstructive pulmonary disease, file ef3a32a1-ee0c-4242-818a-6192ab394841
|
7
|
|
Severity of COVID-19: The importance of being hypertensive, file 782b0edb-593c-4bed-b42c-db73859db187
|
6
|
|
Ambulatory oxygen in interstitial lung disease, file e2188be7-17f1-4564-e053-6605fe0a49d6
|
6
|
|
Cardiovascular function in pulmonary emphysema, file e2188be7-1d50-4564-e053-6605fe0a49d6
|
6
|
|
Something is changing in adherence to CPAP therapy: Real world data after 1 year of treatment in patients with obstructive sleep apnoea, file e2188be7-67b1-4564-e053-6605fe0a49d6
|
6
|
|
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations, file e2188be8-137b-4564-e053-6605fe0a49d6
|
6
|
|
The role of blood gas analysis in the post-acute phase of COVID-19 pneumonia, file ad8508cb-883d-48bf-98bb-f03362bef8ea
|
5
|
|
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients, file e2188be7-3a12-4564-e053-6605fe0a49d6
|
5
|
|
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact, file e2188be7-61d7-4564-e053-6605fe0a49d6
|
5
|
|
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients, file e2188be7-6725-4564-e053-6605fe0a49d6
|
5
|
|
Pulmonary Rehabilitation and Asthma, file e2188be7-6908-4564-e053-6605fe0a49d6
|
5
|
|
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients, file e2188be7-a725-4564-e053-6605fe0a49d6
|
5
|
|
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment, file 4be90e53-86c6-4cc8-87a3-926c7504767a
|
4
|
|
Care-Related intervention in Rehabilitative Pneumology: Pulmonary Rehabilitation in Chronic Obstructive Broncopneumopathies (COPD) can benefit from a multidisciplinary approach? [Cure correlate in Pneumologia Riabilitativa: La Riabilitazione Polmonare nelle Broncopneumopatie Croniche Ostruttive (BPCO) può trarre beneficio da un approccio multidisciplinare?], file aa7013d5-00eb-4dfe-b27e-744a94adc535
|
4
|
|
Is bronchodilator the correct treatment for COPD subjects before EBUS?, file e2188be6-f5d7-4564-e053-6605fe0a49d6
|
4
|
|
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial, file e2188be7-1689-4564-e053-6605fe0a49d6
|
4
|
|
Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity, file e2188be7-17eb-4564-e053-6605fe0a49d6
|
4
|
|
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study, file e2188be7-235a-4564-e053-6605fe0a49d6
|
4
|
|
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns, file e2188be7-61d5-4564-e053-6605fe0a49d6
|
4
|
|
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network, file e2188be7-69ec-4564-e053-6605fe0a49d6
|
4
|
|
Tuberculosis in the time of COVID-19: quality of life and digital innovation, file e2188be7-813a-4564-e053-6605fe0a49d6
|
4
|
|
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung, file e2188be7-8d90-4564-e053-6605fe0a49d6
|
4
|
|
Post-tuberculosis (TB) treatment: The role of surgery and rehabilitation, file e2188be7-b247-4564-e053-6605fe0a49d6
|
4
|
|
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life, file e2188be7-ba40-4564-e053-6605fe0a49d6
|
4
|
|
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment, file e2188be8-0cbd-4564-e053-6605fe0a49d6
|
4
|
|
Electrocardiographic features of patients with COVID-19 pneumonia, file 1553e87e-26de-47c3-804e-3d2779113bf7
|
3
|
|
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD, file e2188be7-0f3d-4564-e053-6605fe0a49d6
|
3
|
|
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases, file e2188be7-1ca8-4564-e053-6605fe0a49d6
|
3
|
|
Post tuberculosis treatment infectious complications, file e2188be7-6176-4564-e053-6605fe0a49d6
|
3
|
|
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases, file e2188be7-61d1-4564-e053-6605fe0a49d6
|
3
|
|
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease, file e2188be7-6723-4564-e053-6605fe0a49d6
|
3
|
|
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease, file e2188be7-6796-4564-e053-6605fe0a49d6
|
3
|
|
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid), file e2188be7-9473-4564-e053-6605fe0a49d6
|
3
|
|
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence, file e2188be7-ae3c-4564-e053-6605fe0a49d6
|
3
|
|
Current developments and future directions in COPD, file e2188be7-b685-4564-e053-6605fe0a49d6
|
3
|
|
An overview of Cochrane systematic reviews for pulmonary rehabilitation interventions in people with chronic obstructive pulmonary disease: a mapping synthesis, file 05c8b282-de81-4413-8279-58baa3b6ac80
|
2
|
|
High-flow oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease and chronic hypoxemia: A multicenter randomized controlled trial, file 14e35335-b9ea-4040-9dfc-6319a2b6c18f
|
2
|
|
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19, file 4640e955-33a5-4d5f-a098-3026134c4754
|
2
|
|
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, file ab15751b-9f63-4785-8cd0-1aafbfb05dd4
|
2
|
|
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night, file e2188be7-17e9-4564-e053-6605fe0a49d6
|
2
|
|
Evolution of programmatic definitions used intuberculosis prevention and care, file e2188be7-235c-4564-e053-6605fe0a49d6
|
2
|
|
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae, file e2188be7-294e-4564-e053-6605fe0a49d6
|
2
|
|
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects, file e2188be7-29ce-4564-e053-6605fe0a49d6
|
2
|
|
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients, file e2188be7-ae40-4564-e053-6605fe0a49d6
|
2
|
|
Minimal clinically important difference of the 6-min walking test in patients with asthma, file e2188be7-d508-4564-e053-6605fe0a49d6
|
2
|
|
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease, file e2188be8-0ce5-4564-e053-6605fe0a49d6
|
2
|
|
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis, file 48a8bc65-6907-4fc7-af77-e37e25699f04
|
1
|
|
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine, file 818a3c07-fae6-4dc9-9d63-c200f80e427a
|
1
|
|
Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitation, file c7dae6cc-c89b-4098-87d7-1add75fd72be
|
1
|
|
Classifying new anti-tuberculosis drugs: rationale and future perspectives, file e2188be6-c858-4564-e053-6605fe0a49d6
|
1
|
|
World TB Day 2017: Strengthening the fight against TB, file e2188be7-177d-4564-e053-6605fe0a49d6
|
1
|
|
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis, file e2188be7-17ee-4564-e053-6605fe0a49d6
|
1
|
|
Intestine: Organ or Apparatus?, file e2188be7-17f4-4564-e053-6605fe0a49d6
|
1
|
|
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: A systematic review, file e2188be7-1e1b-4564-e053-6605fe0a49d6
|
1
|
|
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use, file e2188be7-1e1d-4564-e053-6605fe0a49d6
|
1
|
|
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study, file e2188be7-293e-4564-e053-6605fe0a49d6
|
1
|
|
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico, file e2188be7-29c9-4564-e053-6605fe0a49d6
|
1
|
|
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report, file e2188be7-6799-4564-e053-6605fe0a49d6
|
1
|
|
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease, file ed2c47d0-8f28-4f8b-b29e-c1c637067a79
|
1
|
|
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in Sputum, file f219b19a-453c-4ebf-8ebe-ceba71404d61
|
1
|
| Totale |
1.095 |